Cargando…
The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
Cancer is the leading cause of death worldwide despite the variety of treatments that are currently used. This is due to an innate or acquired resistance to therapy that encourages the discovery of novel therapeutic strategies to overcome the resistance. This review will focus on the role of the pur...
Autores principales: | Janho dit Hreich, Serena, Hofman, Paul, Vouret-Craviari, Valérie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252498/ https://www.ncbi.nlm.nih.gov/pubmed/37298187 http://dx.doi.org/10.3390/ijms24119235 |
Ejemplares similares
-
Protocol for Evaluating In Vivo the Activation of the P2RX7 Immunomodulator
por: Janho dit Hreich, Serena, et al.
Publicado: (2023) -
Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
por: Benzaquen, Jonathan, et al.
Publicado: (2019) -
The Purinergic Landscape of Non-Small Cell Lung Cancer
por: Janho dit Hreich, Serena, et al.
Publicado: (2022) -
P2RX7B is a new theranostic marker for lung adenocarcinoma patients
por: Benzaquen, Jonathan, et al.
Publicado: (2020) -
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
por: Douguet, Laetitia, et al.
Publicado: (2021)